End-of-day quote
Other stock markets
|
||
- EUR | - |
2022 | TCR2 Therapeutics Appoints Chief Business and Strategy Officer | MT |
2021 | Pfizer Deploying Some of Its Covid Cash in Arena Deal -- Analysis | DJ |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Deborah Baron
PSD | President | 55 | 21-11-16 |
Kathleen Large
CTO | Chief Tech/Sci/R&D Officer | 64 | 18-12-31 |
Andrew Muratore
BRD | Director/Board Member | - | 21-11-16 |
Jeff Settleman
PRN | Corporate Officer/Principal | - | - |
Aaron Schimmer
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Deborah Baron
PSD | President | 55 | 21-11-16 |
Andrew Muratore
BRD | Director/Board Member | - | 21-11-16 |
Company contact information
Trillium Therapeutics ULC
1055 West Georgia Street
V6E 3P3, Vancouver
+
http://www.trilliumtherapeutics.comSector
- Stock Market
- Equities
- TRIL Stock
- R5W Stock
- Company Stem Cell Therapeutics Corp.